Balancing Clinical Progress With Economic Sustainability: In Quest of a Courageous Solution-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Balancing Clinical Progress With Economic Sustainability: In Quest of a Courageous Solution

Published:2015-11-10 Issue:32 Volume:33 Page:3841-3842
ISSN:0732-183X
Container-title:Journal of Clinical Oncology
language:en
Short-container-title:JCO

Author:

Fasola Gianpiero¹,Aprile Giuseppe²,Pinto Carmine³

Affiliation:

1. Collegio Italiano dei Primari Oncologi Medici Ospedalieri, and University and General Hospital, Udine, Italy

2. University and General Hospital, Udine, Italy

3. Associazione Italiana di Oncologia Medica, and University and General Hospital, Parma, Italy

Publisher

American Society of Clinical Oncology (ASCO)

Subject

Cancer Research,Oncology

Link

https://ascopubs.org/doi/pdfdirect/10.1200/JCO.2015.61.9601

Reference9 articles.

1. First- and Second-Line Bevacizumab in Addition to Chemotherapy for Metastatic Colorectal Cancer: A United States–Based Cost-Effectiveness Analysis

2. The Just Price of Cancer Drugs and the Growing Cost of Cancer Care: Oncologists Need to Be Part of the Solution

3. Delivering maximum clinical benefit at an affordable price: engaging stakeholders in cancer care

4. Bending the Cost Curve in Cancer Care

5. Updating Cost-Effectiveness — The Curious Resilience of the $50,000-per-QALY Threshold

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A Cost Comparison of Biologic Treatment Regimens for Metastatic Colorectal Cancer in Italy;Global & Regional Health Technology Assessment: Italian; Northern Europe and Spanish;2017-01

2. Apatinib for gastric cancer: are we moving the antiangiogenic strategy any forward?;Translational Cancer Research;2016-10

3. Ramucirumab for the treatment of gastric cancers, colorectal adenocarcinomas, and other gastrointestinal malignancies;Expert Review of Clinical Pharmacology;2016-06-02

4. Reply to A. Messori et al, R. Bordonaro et al, and G. Fasola et al;Journal of Clinical Oncology;2015-11-10

5. Reply to A. Messori et al, R. Bordonaro et al, and G. Fasola et al;Journal of Clinical Oncology;2015-11-10

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3